MDM2 and breast cancer: Another PROTAC tractable target is Rac Family Small GTPase 1 (RAC1), inducing chemoresistance of breast cancer, interacts with co-opted E3 ligases MDM2 and XIAP, and potentially novel E3 ligases, ITCH and SMURF2 (Fig. 5d).